Search results
Professor Paul De Souza has over 20 years of experience caring for patients with cancer, especially those with brain and genitourinary cancer and has a strong interest in clinical research and trials.
Paul DeSouza. Partner. QIC Brisbane Office. Joining QIC in 2006, Paul is a leader in the team’s investment and asset management activities in the government and social sector. He is also a member of the QIC Global Infrastructure Management Committee.
Founder & President, Cyber Security Forum Initiative. Paul is the co-author of the book Strategic Intelligence Management (National Cyber Defense Strategy), serves as an advisor for the MCPA (Military Cyber Professionals Association), and is a recipient of the Order of Thor Medal.
Professor Paul de Souza has clinical interests in genitourinary cancer, brain cancer and rare cancers such as sarcoma. He runs a laboratory at the Ingham Institute, Liverpool Hospital, where he conducts many clinical trials.
Paul DE SOUZA, Professor of Medical Oncology | Cited by 14,102 | of The University of Sydney, Sydney | Read 301 publications | Contact Paul DE SOUZA
Professor Paul De Souza. Adjunct Professor. Medicine & Health. School of Clinical Medicine. Research Interests: As a translational cancer researcher I am interested in applying sound biological and pharmacological principles to overcome the 'Valley of Death' in Drug Development.
A phase 1 dose-escalation study of the poly (ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors. Cancer. [More Information] Redwood, L., Saarinen, K., Ivers, R., Garne, D., De Souza, P., Bonney, A., Rhee, J., Mullan, J., Thomas, S. (2023).
